Inactief instrument

Andere talen Oxford Immunotec Global PLC

Aandelen

OXFD

GB00BGFBB958

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Oxford Immunotec Announces Use of T-SPOT®Discovery SARS-CoV-2 Kit	29-04-21
Oxford Immunotec Global PLC will Change its Name to Oxford Immunotec Global Limited	09-03-21
Oxford Immunotec Global PLC Announces Board Changes	08-03-21
Oxford Immunotec Global PLC(NasdaqGM:OXFD) dropped from S&P Global BMI Index	08-03-21
Oxford Immunotec Global PLC(NasdaqGM:OXFD) dropped from NASDAQ Composite Index	08-03-21
PerkinElmer (UK) Holdings Limited completed the acquisition of Oxford Immunotec Global PLC.	08-03-21
Oxford Immunotec Global PLC's Equity Buyback announced on January 7, 2019, has expired.	08-03-21
Oxford Immunotec Submits Emergency Use Authorization Request to the FDA and CE Marks T-SPOT®.COVID, a Test for the Detection of a Cell Mediated (T cell) Immune Response to SARS-CoV-2 Infection	04-03-21
Oxford Immunotec Global : Plans to Market T Cell Immune Response Measurement Kit to COVID-19 in South Korea	08-02-21
Oxford Immunotec Enters a Memorandum of Understanding (MOU) with GC MS (Green Cross Medical Science Corp. – South Korea) to Market the T-SPOT® Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea	08-02-21
Oxford Immunotec Global PLC Enters into A Memorandum of Understanding Green Cross Medical Science Corp. to Market the T-SPOT Discovery SARS-CoV-2 Kit, for the Measurement of the T Cell Immune Response to SARS-CoV-2 Infection, in South Korea	08-02-21
Oxford Immunotec Updates Their T-SPOT® Discovery SARS-CoV-2 Kit and Include a New Panel to Detect T Cells Reactive to Endemic Coronaviruses	04-02-21
Oxford Immunotec Updates Their T-SPOT® Discovery SARS-Cov-2 Kit and Include New Panel to Detect T Cells Reactive to Endemic Coronaviruses	04-02-21
New Monthly Series Spotlights What 100 Physicians Find to be Critical Needs in Their Battle Against COVID-19	14-01-21
OXFORD IMMUNOTEC INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Oxford Immunotec Global PLC - OXFD	14-01-21
Oxford Immunotec Global : Teams With Valneva on COVID-19 Vaccine Candidate Testing	13-01-21
Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study	13-01-21
Oxford Immunotec’s T-SPOT® Discovery SARS-CoV-2 Test is Used to Measure the Efficacy of Valneva’s VLA2001 COVID-19 Vaccine Candidate in a Phase I/II Clinical Study	13-01-21
Sector Update: Health Care Stocks Add to Early Rise, Supported by Biotech Companies	07-01-21
Sector Update: Modest Advance for Health Care Stocks Despite Larger Gains for Biotechnology Sector	07-01-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Oxford Immunotec Global PLC

Aandelen

OXFD

GB00BGFBB958

Andere talen

Filters